Skip to main content
Top
Published in: Dermatology and Therapy 1/2019

Open Access 01-03-2019 | Alopecia | Original Research

Self-Assessments of Standardized Scalp Massages for Androgenic Alopecia: Survey Results

Authors: Robert S. English Jr., James M. Barazesh

Published in: Dermatology and Therapy | Issue 1/2019

Login to get access

Abstract

Introduction

Standardized scalp massages (SSMs) improve hair thickness in nonbalding men, but their effects on androgenic alopecia (AGA) have not yet been evaluated. The objective of this study was to investigate the effect of SSMs on self-assessed AGA sufferers (SAGASs).

Methods

Between October 2016 and October 2017, 1899 SAGASs searching online for hair loss treatments beyond AGA management drugs accessed literature explaining SSMs as a potential therapy for AGA, then watched a demonstration video detailing twice-daily, 20-min SSMs segmented by three rotational scalp regions using hand-generated presses, pinches, and stretches. In December 2017, SAGASs were contacted once to participate in a retrospective survey study to assess SSM adherence and hair changes. Age, gender, hair loss region and gradient, diet, supplement and topical use, AGA management drug use, estimations for minutes daily and months of massaging, and self-perceived hair changes were reported. Some participants also submitted photosets documenting hair changes throughout SSM adherence.

Results

A total of 340 (17.9%) respondents completed the survey, and 327 (17.2%) reported attempting the SSMs. SSM participants reported a median daily massage effort of 11–20 min and mean adherence of 7.4 ± 6.6 months, with 68.9% reporting hair loss stabilization or regrowth. Estimated minutes daily, months, and total SSM effort (i.e., minutes daily × months) were positively associated with self-perceived hair changes. On average, perceived hair loss stabilization and regrowth occurred after 36.3 h of SSM effort. Results did not vary across age, gender, Norwood gradient, or concomitant supplement, topical, finasteride, minoxidil, or microneedling use. However, hair change improvements were marginally lower for participants reporting diffuse versus frontal/temporal or vertex thinning.

Conclusions

While further research is warranted, these results align with previous findings and suggest the potential for SSMs to improve AGA.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc. 2005;10(3):184–9.PubMedCrossRef Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc. 2005;10(3):184–9.PubMedCrossRef
2.
go back to reference Cash TF. The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol. 1999;141(3):398–405.PubMedCrossRef Cash TF. The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol. 1999;141(3):398–405.PubMedCrossRef
4.
go back to reference Yoo HG, et al. Perifollicular fibrosis: pathogenetic role in androgenetic alopecia. Biol Pharm Bull. 2006;29(6):1246–50.PubMedCrossRef Yoo HG, et al. Perifollicular fibrosis: pathogenetic role in androgenetic alopecia. Biol Pharm Bull. 2006;29(6):1246–50.PubMedCrossRef
5.
go back to reference Kaufman KD, et al. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss). Eur J Dermatol. 2008;18(4):400–6.PubMed Kaufman KD, et al. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss). Eur J Dermatol. 2008;18(4):400–6.PubMed
6.
go back to reference Kaufman KD, Finasteride Male Pattern Hair Loss Study Group, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578–89.PubMedCrossRef Kaufman KD, Finasteride Male Pattern Hair Loss Study Group, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578–89.PubMedCrossRef
7.
go back to reference Olsen EA, et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007;57(5):767–74.PubMedCrossRef Olsen EA, et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007;57(5):767–74.PubMedCrossRef
8.
go back to reference Mapar MA, Omidian M. Is topical minoxidil solution effective on androgenetic alopecia in routine daily practice? J Dermatolog Treat. 2007;18(5):268–70.PubMedCrossRef Mapar MA, Omidian M. Is topical minoxidil solution effective on androgenetic alopecia in routine daily practice? J Dermatolog Treat. 2007;18(5):268–70.PubMedCrossRef
10.
go back to reference Fertig RM, et al. Microneedling for the treatment of hair loss? J Eur Acad Dermatol Venereol. 2018;32(4):564–9.PubMedCrossRef Fertig RM, et al. Microneedling for the treatment of hair loss? J Eur Acad Dermatol Venereol. 2018;32(4):564–9.PubMedCrossRef
11.
go back to reference Bharti J, et al. Scalp threading with polydioxanone monofilament threads: a novel, effective and safe modality for hair restoration. J Eur Acad Dermatol Venereol. 2017;31(11):e492–3.PubMedCrossRef Bharti J, et al. Scalp threading with polydioxanone monofilament threads: a novel, effective and safe modality for hair restoration. J Eur Acad Dermatol Venereol. 2017;31(11):e492–3.PubMedCrossRef
12.
13.
go back to reference Best TM, Gharaibeh B, Huard J. Stem cells, angiogenesis and muscle healing: a potential role in massage therapies? Postgrad Med J. 2013;89(1057):666–70.PubMedCrossRef Best TM, Gharaibeh B, Huard J. Stem cells, angiogenesis and muscle healing: a potential role in massage therapies? Postgrad Med J. 2013;89(1057):666–70.PubMedCrossRef
14.
go back to reference Koyama T, et al. Standardized scalp massage results in increased hair thickness by inducing stretching forces to dermal papilla cells in the subcutaneous tissue. Eplasty. 2016;16:e8.PubMedPubMedCentral Koyama T, et al. Standardized scalp massage results in increased hair thickness by inducing stretching forces to dermal papilla cells in the subcutaneous tissue. Eplasty. 2016;16:e8.PubMedPubMedCentral
15.
go back to reference Andrzejewski W, et al. Effects of synergistic massage and physical exercise on the expression of angiogenic markers in rat tendons. Biomed Res Int. 2014;2014:878095.PubMedPubMedCentralCrossRef Andrzejewski W, et al. Effects of synergistic massage and physical exercise on the expression of angiogenic markers in rat tendons. Biomed Res Int. 2014;2014:878095.PubMedPubMedCentralCrossRef
17.
go back to reference Andrzejewski W, et al. Massage may initiate tendon structural changes—a preliminary study. Vivo. 2015;29(3):365–9. Andrzejewski W, et al. Massage may initiate tendon structural changes—a preliminary study. Vivo. 2015;29(3):365–9.
18.
go back to reference Cho YS, et al. The effect of burn rehabilitation massage therapy on hypertrophic scar after burn: a randomized controlled trial. Burns. 2014;40(8):1513–20.PubMedCrossRef Cho YS, et al. The effect of burn rehabilitation massage therapy on hypertrophic scar after burn: a randomized controlled trial. Burns. 2014;40(8):1513–20.PubMedCrossRef
19.
go back to reference Agarwal S, et al. A central role for the nuclear factor-kappaB pathway in anti-inflammatory and proinflammatory actions of mechanical strain. FASEB J. 2003;17(8):899–901.PubMedPubMedCentralCrossRef Agarwal S, et al. A central role for the nuclear factor-kappaB pathway in anti-inflammatory and proinflammatory actions of mechanical strain. FASEB J. 2003;17(8):899–901.PubMedPubMedCentralCrossRef
20.
21.
go back to reference Chapman RS, Main RA. Diffuse thinning of hair in iodide-induced hypothyroidism. Br J Dermatol. 1967;79(2):103–5.PubMedCrossRef Chapman RS, Main RA. Diffuse thinning of hair in iodide-induced hypothyroidism. Br J Dermatol. 1967;79(2):103–5.PubMedCrossRef
22.
go back to reference Keen MA, Hassan I, Bhat MH. A clinical study of the cutaneous manifestations of hypothyroidism in Kashmir valley. Indian J Dermatol. 2013;58(4):326.PubMedPubMedCentral Keen MA, Hassan I, Bhat MH. A clinical study of the cutaneous manifestations of hypothyroidism in Kashmir valley. Indian J Dermatol. 2013;58(4):326.PubMedPubMedCentral
24.
go back to reference Betsy A, Binitha M, Sarita S. Zinc deficiency associated with hypothyroidism: an overlooked cause of severe alopecia. Int J Trichol. 2013;5(1):40–2.CrossRef Betsy A, Binitha M, Sarita S. Zinc deficiency associated with hypothyroidism: an overlooked cause of severe alopecia. Int J Trichol. 2013;5(1):40–2.CrossRef
26.
go back to reference English RS Jr. A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors. Med Hypotheses. 2018;111:73–81.PubMedCrossRef English RS Jr. A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors. Med Hypotheses. 2018;111:73–81.PubMedCrossRef
27.
go back to reference Smith LS. Evaluation and management of the muscle contraction headache. Nurse Pract. 1988;13(1):20–3.PubMedCrossRef Smith LS. Evaluation and management of the muscle contraction headache. Nurse Pract. 1988;13(1):20–3.PubMedCrossRef
28.
go back to reference Toshitani S, et al. A new apparatus for hair regrowth in male-pattern baldness. J Dermatol. 1990;17(4):240–6.PubMedCrossRef Toshitani S, et al. A new apparatus for hair regrowth in male-pattern baldness. J Dermatol. 1990;17(4):240–6.PubMedCrossRef
29.
go back to reference Freund BJ, Schwartz M. Treatment of male pattern baldness with botulinum toxin: a pilot study. Plast Reconstr Surg. 2010;126(5):246e–8e.PubMedCrossRef Freund BJ, Schwartz M. Treatment of male pattern baldness with botulinum toxin: a pilot study. Plast Reconstr Surg. 2010;126(5):246e–8e.PubMedCrossRef
31.
go back to reference Mather M, Johnson MK. Choice-supportive source monitoring: do our decisions seem better to us as we age? Psychol Aging. 2000;15(4):596–606.PubMedCrossRef Mather M, Johnson MK. Choice-supportive source monitoring: do our decisions seem better to us as we age? Psychol Aging. 2000;15(4):596–606.PubMedCrossRef
32.
go back to reference Schoeller DA. Limitations in the assessment of dietary energy intake by self-report. Metabolism. 1995;44(2 Suppl 2):18–22.PubMedCrossRef Schoeller DA. Limitations in the assessment of dietary energy intake by self-report. Metabolism. 1995;44(2 Suppl 2):18–22.PubMedCrossRef
33.
go back to reference Spencer EA, et al. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr. 2002;5(4):561–5.PubMedCrossRef Spencer EA, et al. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr. 2002;5(4):561–5.PubMedCrossRef
34.
go back to reference Filip JC, et al. Mail surveys can achieve high response rates in a dermatology patient population. J Invest Dermatol. 2004;122(1):39–43.PubMedCrossRef Filip JC, et al. Mail surveys can achieve high response rates in a dermatology patient population. J Invest Dermatol. 2004;122(1):39–43.PubMedCrossRef
35.
go back to reference Glazer A, et al. Comparison of survey modality and response rate in dermatologists’ perceptions and opinions of sunscreens. SKIN J Cutan Med. 2018;2(2):5. Glazer A, et al. Comparison of survey modality and response rate in dermatologists’ perceptions and opinions of sunscreens. SKIN J Cutan Med. 2018;2(2):5.
Metadata
Title
Self-Assessments of Standardized Scalp Massages for Androgenic Alopecia: Survey Results
Authors
Robert S. English Jr.
James M. Barazesh
Publication date
01-03-2019
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 1/2019
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-019-0281-6

Other articles of this Issue 1/2019

Dermatology and Therapy 1/2019 Go to the issue